🔗 Share this article

A shadow market for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Experimental Drug Gaining Traction Via Social Media

Retatrutide, which remains in research studies, is being promoted by social media influencers for its alleged weight-reducing properties. Followers are encouraged to contact these profiles directly for supplier links, while also obtaining discount codes.

Thriving Trade on Social Networks

Additionally, a flourishing market exists on Telegram, where communities with numerous of members share “before and after” images, injection guides and claims of rapid British shipping. Sellers market the drug there before redirecting customers to other platforms for transactions.

Understanding Retatrutide

Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Medical Experts Express Concerns

However, doctors and chemists have cautions that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals injecting products of uncertain source.

Some professionals stated the popularity for retatrutide could be connected to the increasing cost of licensed weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Marketing the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be promoted or supplied for human use under the British medical regulations.

Some content creators attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate medicines, advertising, and customer regulations, risking fines, legal action or prison.

Platform Reaction and Material Removal

According to TikTok, the platform has taken down violative content and prohibited related keywords and search suggestions. The organization said it was dedicated to maintaining the platform secure and investing in strengthening enforcement strategies.

Digital Trading Operations

Investigations also found groups with up to nine thousand members selling retatrutide using the platform's integrated search feature, which functions like a online catalog. Typing “retatrutide” instantly displays channels with thousands of members, populated with images of slimming results, positive testimonials and step-by-step guides for mixing or administering at residence.

Within minutes of entering one community, a vendor shared WhatsApp details, where most purchases occur. The seller sent an guidebook and promised delivery within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about weight, health issues or past usage.

Item Information and Costs

Inside these groups, messages show black plastic parcels with Royal Mail stickers, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with purified liquid, or pre-filled injectors typically priced at £160 for 20mg. When questioned how much time a pen should last, sellers give conflicting answers varying between a several days to “depends on your body”.

Platform Moderation and Security Actions

A representative for the messaging service stated it actively monitored dangerous material on its platform including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are administering materials they can’t verify. Although the science behind this drug is valid, these online versions may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With costs rising, patients are using online platforms. But fake injections are highly dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.

Her team has already seen patients harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but buying from messaging apps or communication platforms is gambling with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated retatrutide was in third stage research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company investigational substance not yet approved … may subject patients to potentially significant medical dangers”.